Effect of VOMI - DEK sublingual film in comparison to doxylamine succinate with pyridoxine tablet in the management of vomiting due to pregnancy.

A Study To Evaluate The Reproductive Toxicity And Efficacy Of VOMI-DEK Film In The Management Of Garbhini Chhardi w.s.r. To Emesis Gravidarum. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098926

Enrollment

Registered

2025-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O368- Maternal care for other specifiedfetal problems

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women of 1st trimester of pregnancy from 6 to 12 weeks, Pregnant women with complaints of chhardi, hrullasa and aruchi, Age 18-40 years, Both primi and multi gravida.

Exclusion criteria

Exclusion criteria: Pregnant women not willing for trial, Pregnant women with hyperemesis gravidarum, Pregnant women with other systemic disorders like appendicitis, peptic ulcer, IBS, hepatitis, diabetes, hypertension, VDRL +, etc., Pregnant women with molar pregnancy and ectopic pregnancy.

Design outcomes

Primary

Measure	Time frame
To find an alternative, safe and rapidly effective remedy for garbhini chhardi w.s.r to emesis gravidarum. To evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.Timepoint: To find an alternative, safe and rapidly effective remedy and to evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.	—

Measure

Time frame

To find an alternative, safe and rapidly effective remedy for garbhini chhardi w.s.r to emesis gravidarum. To evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.Timepoint: To find an alternative, safe and rapidly effective remedy and to evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.

—

Secondary

Measure	Time frame
To find an alternative, safe & rapidly effective remedy for garbhini chhardi w.s.r to emesis gravidarum. To evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.Timepoint: To find an alternative, safe & rapidly effective remedy & to evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.	—

Measure

Time frame

To find an alternative, safe & rapidly effective remedy for garbhini chhardi w.s.r to emesis gravidarum. To evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.Timepoint: To find an alternative, safe & rapidly effective remedy & to evaluate the efficacy of Vomi-DEK film in the management of garbhini chhardi w.s.r. to emesis gravidarum when compared to standard controlled drug.

—

Countries

India

Contacts

Public ContactDR MAULI VAISHNAV

PARUL INSTITUTE OF AYURVEDA

mauli.vaishnav36886@paruluniversity.ac.in9589788336

Outcome results